skinny.

Latest / Neuro-Oncology: The Podcast

Neuro-Oncology Nugget: GT-20 Phase 1 Trial — Personalized Neoantigen DNA Vaccine for MGMT Unmethylated Glioblastoma

Host/Interviewee: ç, PhD Candidate, UT Health San Antonio

Description: Shahad Abdulsahib discusses the GT-20 phase 1 clinical trial evaluating GNOS-PV01, a personalized multivalent neoantigen DNA vaccine administered following surgical resection and radiation in patients with MGMT unmethylated glioblastoma, with findings published in Nature Cancer on May 12th, 2026.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.